Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11951 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850192654911930368 |
|---|---|
| author | Ziyu Feng Xiaohui Hu Weiyang Li Ting Xu Yang Xu Shengli Xue Huiying Qiu Xiaowen Tang Yue Han Suning Chen Aining Sun Yanming Zhang Depei Wu Ying Wang |
| author_facet | Ziyu Feng Xiaohui Hu Weiyang Li Ting Xu Yang Xu Shengli Xue Huiying Qiu Xiaowen Tang Yue Han Suning Chen Aining Sun Yanming Zhang Depei Wu Ying Wang |
| author_sort | Ziyu Feng |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-7c001fd0ef8741a0b8e8a2ac2d2d690a |
| institution | OA Journals |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-7c001fd0ef8741a0b8e8a2ac2d2d690a2025-08-20T02:14:28ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-02-01999110.3324/haematol.2024.286836Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemiaZiyu Feng0Xiaohui Hu1Weiyang Li2Ting Xu3Yang Xu4Shengli Xue5Huiying Qiu6Xiaowen Tang7Yue Han8Suning Chen9Aining Sun10Yanming Zhang11Depei Wu12Ying Wang13National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, SuzhouDepartment of Hematology, The Second People's Hospital of Huai'an, Huai'anNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China; State Key Laboratory of Radiation Medicine and Protection, Soochow University, SuzhouNational Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou Not available. https://haematologica.org/article/view/11951 |
| spellingShingle | Ziyu Feng Xiaohui Hu Weiyang Li Ting Xu Yang Xu Shengli Xue Huiying Qiu Xiaowen Tang Yue Han Suning Chen Aining Sun Yanming Zhang Depei Wu Ying Wang Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia Haematologica |
| title | Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia |
| title_full | Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia |
| title_fullStr | Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia |
| title_full_unstemmed | Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia |
| title_short | Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia |
| title_sort | venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed i cbf i β i myh11 i acute myeloid leukemia |
| url | https://haematologica.org/article/view/11951 |
| work_keys_str_mv | AT ziyufeng venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT xiaohuihu venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT weiyangli venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT tingxu venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT yangxu venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT shenglixue venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT huiyingqiu venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT xiaowentang venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT yuehan venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT suningchen venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT ainingsun venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT yanmingzhang venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT depeiwu venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia AT yingwang venetoclaxincombinationwithhypomethylatingagentsinnewlydiagnosedandrelapsedicbfibimyh11iacutemyeloidleukemia |